Shire Strategic Investment Group Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 8

  • Exits
  • 5

Exits

Shire Strategic Investment Group General Information

Company Description

Shire Strategic Investment Group was Shire's corporate venture fund, tasked with identifying and investing in external innovation that may bring new products to Shire's pipeline and which support Shire's mission to enable people with life-altering conditions to lead better lives. Further to that mission, Shire was focused on delivering novel, cost-effective therapies to patients with symptomatic diseases and significant unmet medical need. Accordingly, the SIG sought to invest across a broad range of therapeutic areas of interest including central nervous system/neuropsychiatry, gastrointestinal, orphan genetic diseases, allergy, and hematology.

Business Details

Year Founded
2011
Investor Status
Out of Business
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Corporate Office
  • 725 Chesterbrook Boulevard
  • Wayne, PA 19087
  • United States

Shire Strategic Investment Group Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Aptinyx 15-Sep-2015 Seed Round Drug Discovery Bankruptcy: Liquidation
Proclara Biosciences 06-May-2013 Drug Discovery Out of Business
Naurex 17-Dec-2012 Drug Discovery Clinical Trials - Phase 3
Promedior 15-Oct-2012 Drug Discovery Clinical Trials - Phase 2
Proclara Biosciences 08-Mar-2012 Drug Discovery Out of Business
Naurex 11-May-2011 Drug Discovery Clinical Trials - Phase 3
Prexa Pharmaceuticals 11-May-2011 Early Stage VC Pharmaceuticals Out of Business
Proclara Biosciences 01-Mar-2011 Later Stage VC Drug Discovery Out of Business
To view Shire Strategic Investment Group’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shire Strategic Investment Group Exits (5)

Company Name Exit Date Exit Type Exit Size
Promedior 13-Feb-2020 Merger/Acquisition
Proclara Biosciences 31-Jul-2019
Aptinyx 21-Jun-2018
Naurex 28-Aug-2015 Merger/Acquisition
Prexa Pharmaceuticals 01-May-2015 Out of Business
To view Shire Strategic Investment Group’s complete exits history, request access »

Shire Strategic Investment Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Shire Strategic Investment Group FAQs

  • What is Shire Strategic Investment Group?

    Shire Strategic Investment Group was Shire's corporate venture fund, tasked with identifying and investing in external innovation that may bring new products to Shire's pipeline and which support Shire's mission to enable people with life-altering conditions to lead better lives.

  • When was Shire Strategic Investment Group founded?

    Shire Strategic Investment Group was founded in 2011.

  • Where is Shire Strategic Investment Group headquartered?

    Shire Strategic Investment Group is headquartered in Wayne, PA.

  • How many investments has Shire Strategic Investment Group made?

    Shire Strategic Investment Group has made 8 investments.

  • What has Shire Strategic Investment Group invested in?

    Shire Strategic Investment Group has made numerous investments in companies like Aptinyx, Proclara Biosciences, and Naurex within the Drug Discovery industry.

  • What has Shire Strategic Investment Group invested in recently?

    Shire Strategic Investment Group's latest investment was on 15-Sep-2015 in Aptinyx, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process